Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
about
Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patientsPhage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa InfectionsCeftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combinationPredicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive patients with healthcare-associated pneumoniaMitophagy confers resistance to siderophore-mediated killing by Pseudomonas aeruginosaAntibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.Pseudomonas pyocyanin stimulates IL-8 expression through MAPK and NF-κB pathways in differentiated U937 cells.Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections.Imipenem resistance of Pseudomonas in pneumonia: a systematic literature reviewEconomic burden of healthcare-associated infections: an American perspective.ATP7B detoxifies silver in ciliated airway epithelial cells.Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in ItalyDraft Genome Sequence of Colistin-Only-Susceptible Pseudomonas aeruginosa Strain ST235, a Hypervirulent High-Risk Clone in Spain.Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.Clinical and treatment-related risk factors for nosocomial colonisation with extensively drug-resistant Pseudomonas aeruginosa in a haematological patient population: a matched case control study.Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomesIn vitro activity of ceftazidime combined with NXL104 versus Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals (CANWARD 2009 study).Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Marine-derived quorum-sensing inhibitory activities enhance the antibacterial efficacy of tobramycin against Pseudomonas aeruginosaThe determinants of the antibiotic resistance process.Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.Virulence Gene Profiles of Multidrug-Resistant Pseudomonas aeruginosa Isolated From Iranian Hospital Infections.Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective studyImpact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit.Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposureClinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistanceChanges in diversity of cultured bacteria resistant to erythromycin and tetracycline in swine manure during simulated composting and lagoon storage.PredSTP: a highly accurate SVM based model to predict sequential cystine stabilized peptides.A Year of Infection in the Intensive Care Unit: Prospective Whole Genome Sequencing of Bacterial Clinical Isolates Reveals Cryptic Transmissions and Novel Microbiota.Class 1 integron and Imipenem Resistance in Clinical Isolates of Pseudomonas aeruginosa: Prevalence and Antibiotic Susceptibility.Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period.Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections.In vitro evaluation of novel compounds against selected resistant Pseudomonas aeruginosa isolatesClinical and Molecular Epidemiology of Multidrug-Resistant P. aeruginosa Carrying aac(6')-Ib-cr, qnrS1 and blaSPM Genes in Brazil.VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain
P2860
Q24673399-1858D573-0E02-445A-9C2A-08626FBBB450Q26823401-8A39388F-4AC3-4C92-B0C4-B23C8DD7341AQ26998883-EA840A45-2406-4339-8DBE-0174F318F0BFQ27334131-E082FE51-5D99-4908-87F0-0CE4EAAF308AQ28255998-02051554-FD57-4F4E-8E1C-8D27CE406F7DQ28545750-27D56412-BD3F-479B-8EE3-638FB07A6911Q30419577-9DF78CFA-94E6-47EF-B7D8-D7F33979BA26Q31034219-5DA3FA68-50A6-4813-A311-68100AE04A66Q31150329-12D4A571-69BC-4163-AA78-942CB00511A2Q33617939-6B7D854C-60D4-4068-A472-476BE793966BQ33675546-73356E00-4855-4BD2-9BB8-D599E4FEF275Q33685288-272A3643-E380-441F-8396-F1A9B352C4C4Q33695461-3414C820-4C4A-4E2F-B0F3-D81304CD628DQ33853131-7E1AEC34-758C-4F09-B3AF-49D2534EC9F6Q34205018-CFEEB639-ECE0-42ED-98B1-91A561276F8EQ34429763-8BD76DE3-6A6B-4EAE-BD4A-543E445F0E4CQ34446914-1BF3202C-9F54-488F-B8C1-50E6E90AD13AQ34700642-D614A473-F4F4-4384-A4AE-21AE3CF8850CQ34726682-3B2AFC03-6511-41BC-8A40-2ACFF38CC85EQ34766191-3CF5776D-F621-4A8B-86AC-36398F37E4FCQ35004966-E3A8997D-8DF5-4911-B97F-5EEF6ABD9185Q35007624-27CD8921-E517-4775-9FC8-399D4B7134E3Q35015292-4CA8A8EE-D7E3-47B7-BC22-943A69448AC5Q35026542-A91FDFAC-6D32-46BB-8986-D65E86D08B18Q35029541-E93F6EED-1873-4E34-812A-8EB24A989A46Q35087141-4354451A-9868-4B1E-B7D2-1A8E1440D41BQ35110953-C839B87C-078C-415D-8637-48DB482F83F0Q35559596-D8D1F120-0931-4DE3-A013-5EF309C54CF1Q35570372-0BAF8813-668B-4DA7-9700-D874C0E7B74DQ35608657-02707066-951A-49AE-A57B-97D8D8FA0D62Q35635895-6814497D-0F16-44C9-BD38-DED444B817B1Q35648759-B3A88A10-C9F3-4749-95C6-8354B1BC4C6CQ35682704-D7BB47E6-C063-4794-8A5A-A649D37F008DQ35730315-78440A6A-38B6-4E0A-B2C5-8A36EA3C9951Q35757894-BA0BF6AD-B065-4769-B81E-1C80B33E91E7Q35796552-F974BCC0-AC7C-4ADF-B5A9-FF13048BABC6Q35806150-F2F30C7E-DA03-46CE-A583-F489A6203F50Q35806165-E2CC4343-2897-42D3-9899-78ACA92B7D64Q36027868-386C9733-243C-454D-BCD5-461664FA318DQ36147987-53F9EA83-23F3-49C9-976F-840BAB37F82D
P2860
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@ast
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@en
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@nl
type
label
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@ast
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@en
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@nl
prefLabel
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@ast
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@en
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
@nl
P2093
P2860
P1476
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact
@en
P2093
Shaltiel Cabili
Valerie Aloush
Yardena Seigman-Igra
Yehuda Carmeli
P2860
P356
10.1128/AAC.50.1.43-48.2006
P407
P577
2006-01-01T00:00:00Z